BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 8058310)

  • 1. The human A-myb protein is a strong activator of transcription.
    Golay J; Loffarelli L; Luppi M; Castellano M; Introna M
    Oncogene; 1994 Sep; 9(9):2469-79. PubMed ID: 8058310
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The chicken A-myb protein is a transcriptional activator.
    Foos G; Grimm S; Klempnauer KH
    Oncogene; 1994 Sep; 9(9):2481-8. PubMed ID: 8058311
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Transcriptional activation of the c-myc gene by the c-myb and B-myb gene products.
    Nakagoshi H; Kanei-Ishii C; Sawazaki T; Mizuguchi G; Ishii S
    Oncogene; 1992 Jun; 7(6):1233-40. PubMed ID: 1594249
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Myb oncogene product induces DNA-bending.
    Saikumar P; Gabriel JL; Reddy EP
    Oncogene; 1994 Apr; 9(4):1279-87. PubMed ID: 8134132
    [TBL] [Abstract][Full Text] [Related]  

  • 5. DNA binding and transactivation activity of A-myb, a c-myb-related gene.
    Ma XP; Calabretta B
    Cancer Res; 1994 Dec; 54(24):6512-6. PubMed ID: 7987850
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Myb DNA-binding domain is highly conserved in Dictyostelium discoideum.
    Stober-Grässer U; Brydolf B; Bin X; Grässer F; Firtel RA; Lipsick JS
    Oncogene; 1992 Mar; 7(3):589-96. PubMed ID: 1549373
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interaction of the v-and c-Myb proteins with regulatory sequences of the human c-myc gene.
    Zobel A; Kalkbrenner F; Guehmann S; Nawrath M; Vorbrueggen G; Moelling K
    Oncogene; 1991 Aug; 6(8):1397-407. PubMed ID: 1679531
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Human telomeres contain two distinct Myb-related proteins, TRF1 and TRF2.
    Broccoli D; Smogorzewska A; Chong L; de Lange T
    Nat Genet; 1997 Oct; 17(2):231-5. PubMed ID: 9326950
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Solution structure of the B-Myb DNA-binding domain: a possible role for conformational instability of the protein in DNA binding and control of gene expression.
    McIntosh PB; Frenkiel TA; Wollborn U; McCormick JE; Klempnauer KH; Feeney J; Carr MD
    Biochemistry; 1998 Jul; 37(27):9619-29. PubMed ID: 9657674
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Murine A-myb: evidence for differential splicing and tissue-specific expression.
    Mettus RV; Litvin J; Wali A; Toscani A; Latham K; Hatton K; Reddy EP
    Oncogene; 1994 Oct; 9(10):3077-86. PubMed ID: 8084617
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Transcriptional regulation by the carboxyl terminus of c-Myb depends upon both the Myb DNA-binding domain and the DNA recognition site.
    Dubendorff JW; Lipsick JS
    Oncogene; 1999 Jun; 18(23):3452-60. PubMed ID: 10376523
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Myb binding sites within the N-ras promoter repress transcription.
    Ganter B; Lipsick JS
    Oncogene; 1997 Jul; 15(2):193-202. PubMed ID: 9244354
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cell type-specific trans-activation by the B-myb gene product: requirement of the putative cofactor binding to the C-terminal conserved domain.
    Tashiro S; Takemoto Y; Handa H; Ishii S
    Oncogene; 1995 May; 10(9):1699-707. PubMed ID: 7753546
    [TBL] [Abstract][Full Text] [Related]  

  • 14. NMR structure of the hRap1 Myb motif reveals a canonical three-helix bundle lacking the positive surface charge typical of Myb DNA-binding domains.
    Hanaoka S; Nagadoi A; Yoshimura S; Aimoto S; Li B; de Lange T; Nishimura Y
    J Mol Biol; 2001 Sep; 312(1):167-75. PubMed ID: 11545594
    [TBL] [Abstract][Full Text] [Related]  

  • 15. TATA-box dependent trans-activation of the human HSP70 promoter by Myb proteins.
    Foos G; Natour S; Klempnauer KH
    Oncogene; 1993 Jul; 8(7):1775-82. PubMed ID: 8510924
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nitric oxide-releasing agents and cGMP analogues inhibit murine erythroleukemia cell differentiation and suppress erythroid-specific gene expression: correlation with decreased DNA binding of NF-E2 and altered c-myb mRNA expression.
    Suhasini M; Boss GR; Pascual FE; Pilz RB
    Cell Growth Differ; 1995 Dec; 6(12):1559-66. PubMed ID: 9019161
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Viral myb oncogene encodes a sequence-specific DNA-binding activity.
    Biedenkapp H; Borgmeyer U; Sippel AE; Klempnauer KH
    Nature; 1988 Oct; 335(6193):835-7. PubMed ID: 3185713
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Construction of an artificial tandem protein of the c-Myb DNA-binding domain and analysis of its DNA binding specificity.
    Oda M; Furukawa K; Sarai A; Nakamura H
    Biochem Biophys Res Commun; 1999 Aug; 262(1):94-7. PubMed ID: 10448074
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The conserved DNA binding domain mediates similar regulatory interactions for A-Myb, B-Myb, and c-Myb transcription factors.
    Rushton JJ; Ness SA
    Blood Cells Mol Dis; 2001; 27(2):459-63. PubMed ID: 11259168
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The carboxy-terminal domain of c-Myb activates reporter gene expression in yeast.
    Seneca S; Punyammalee B; Sureau A; Perbal B; Dvorák M; Crabeel M
    Oncogene; 1993 Sep; 8(9):2335-42. PubMed ID: 8361752
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.